Regulated AI architecture

Compliance as architecture, not paperwork.

Brandlabs Compliance10 min

TL;DR

HIPAA and DPDP fail late when they are treated as a launch checklist. Brandlabs designs access control, audit logging, consent, data minimization, and vendor BAAs into the first architecture so eval gates and product UX inherit the same posture.

Why does last-mile compliance break AI products?

Retrofits force painful rewrites of logging, storage, vendor choices, and UX. Models make this worse: prompts, traces, and eval datasets become new PHI/PII surfaces. If compliance is not in the first commit, you will pay for the architecture twice.

Checklists catch policies. They do not catch systems.

AI products add surfaces classic SaaS reviews miss: prompt logs, retrieved chunks, tool outputs, and third-party model APIs. Designing those late means choosing between velocity and credibility — a false choice if you sequenced correctly.

What does “compliance in the first commit” actually mean?

It means threat-modeling data flows before feature thrash: where PHI/PII enters, where it is stored, which vendors touch it, how consent is captured, and how every inference is auditable. Those decisions become defaults in code, infra, and eval fixtures — not a slide in week 16.

Practically, Foundation phase includes:

  • Data-flow diagram with trust boundaries
  • Vendor list with BAA / DPDP processor status
  • Audit log schema for auth and inference events
  • Consent and notice UX for the jurisdictions you sell into
  • Redaction and retention defaults

US buyers hear HIPAA. Indian buyers hear DPDP. The shared spine is minimization, access control, auditability, and honest subprocessors.

How do evals and compliance reinforce each other?

Safety and privacy behaviors belong in the eval suite: PII leakage tests, refusal cases, and “no retrieval → no answer” checks. Compliance architecture without evals is policy. Evals without compliance architecture are cosplay. Together they make regulated shipping repeatable.

When a postmortem finds a leakage path, it becomes a regression fixture. When a vendor changes retention defaults, the architecture review and the suite both update.

That loop is how Brandlabs keeps “evaluated, compliant, shipped” from becoming three disconnected slogans.

Frequently asked questions

Do we need a BAA before any prototype?

You need a clear rule: no real PHI until BAAs and environment controls exist. Prototypes can use synthetic or properly de-identified data. Crossing that line early is how teams inherit avoidable risk.

Is DPDP just “India GDPR”?

No. There is overlap in spirit (notice, purpose, security) but obligations, definitions, and operational patterns differ. Design for your actual buyers’ jurisdictions instead of copying a US HIPAA checklist onto an India launch.

Can we use a general-purpose LLM API for healthcare?

Only with a vendor posture that matches your risk: contractual safeguards, retention controls, region options, and an architecture that minimizes what you send. Model quality rankings are not a compliance strategy.

Related insights